ASXL1 and acute myeloid leukemia: ASXL1 is frequently mutated in patients with different types of myeloid malignancies, including myelodysplastic syndromes (MDS), myeloproliferative neoplasms, chronic myelomonocytic leukemia, and AML with MDS-related alterations [20].